Development and Validation of a Detection System for Wild-type Vibrio cholerae in Genetically Modified Cholera Vaccine

Orochol®, a live oral cholera vaccine licensed in Switzerland and in other countries, is based on the genetically modified Vibrio cholerae strain CVD103-HgR. This strain is derived from the wild-type O1 strain Inaba 569B by deletion of a fragment internal to the ctxA gene encoding the A1 subunit of...

Full description

Saved in:
Bibliographic Details
Published in:Biologicals 2000-09, Vol.28 (3), p.149-154
Main Authors: Studer, Edgar, Candrian, Urs
Format: Article
Language:English
Subjects:
Cholera Toxin - genetics
Cholera Toxin - immunology
Cholera Vaccines - standards
Confidence Intervals
ctxA gene
DNA Primers
Drug Contamination
mer operon
Oligodeoxyribonucleotides, Antisense
Polymerase Chain Reaction - methods
Quality Control
Reproducibility of Results
Sensitivity and Specificity
Sequence Deletion
Vaccines, DNA - standards
Vibrio cholerae
Vibrio cholerae - genetics
Vibrio cholerae - isolation & purification
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Orochol®, a live oral cholera vaccine licensed in Switzerland and in other countries, is based on the genetically modified Vibrio cholerae strain CVD103-HgR. This strain is derived from the wild-type O1 strain Inaba 569B by deletion of a fragment internal to the ctxA gene encoding the A1 subunit of cholera toxin and by replacement of an internal fragment of the hlyA gene with a fragment carrying the mer operon mediating mercury resistance. In this study we describe a polymerase chain reaction (PCR) system for the detection of wild-type Vibrio cholerae and the identification of the vaccine strain for the quality control of production batches. A multiplex PCR system that targets the intactctxA gene of the wild-type strain and simultaneously the integration site of the mer operon in the hlyA gene (hlyA::mer) of the vaccine strain CVD103-HgR was developed. To evaluate the detection limit of the system, vaccine suspensions were artificially contaminated with wild-type V. cholerae 569B cells and tested by PCR. The detection limit of the system was statistically evaluated and found to be at 11625 wild-type cells per vaccine sachet (95% confidence limit). This number is below the infective dose of wild-type Vibrio cholerae. In Switzerland this test is used in combination with other tests in the official batch-release procedure to assure the safety of each batch of the cholera vaccine Orochol®.
ISSN:1045-1056
1095-8320
DOI:10.1006/biol.2000.0252